Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients [Phase 3]
Phase 3 clinical trial evaluating dexmedetomidine to attenuate haemodynamic responses to laryngoscopy in controlled hypertensive patients ha…
-
EMA approval · 2026-04-28EMA Authorised: Micardis (telmisartan) — Boehringer Ingelheim International GmbH
Micardis (telmisartan) has been authorised for use in Europe by Boehringer Ingelheim International GmbH for hypertension.
-
EMA approval · 2026-04-28EMA Authorised: MicardisPlus (telmisartan;hydrochlorothiazide) — Boehringer Ingelheim International GmbH
MicardisPlus (telmisartan and hydrochlorothiazide) has been authorised by the EMA for hypertension.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Self-Management and Resilience Trajectories in African American Adults With Hypertension
Completed clinical trial evaluating self-management and resilience trajectories in African American adults with hypertension; results have b…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin [Phase 4]
Phase 4 trial update on the efficacy and safety of triple therapy telmisartan/amlodipine/rosuvastatin for hypertension and dyslipidemias.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension [Phase 2]
This Phase 2 trial assessed the safety and effects of 5 mg and 10 mg oral SLx-2101 given for 14 days in patients with hypertension; the stud…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension [NA]
A completed clinical trial comparing remote patient monitoring and health coaching versus usual care for hypertension; the snippet does not …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Clinical trial update indicates ongoing recruitment for using clevidipine to treat acute intracerebral hemorrhage, focusing on antihypertens…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss [NA]
A clinical trial update from a Brazilian university examining how eating window schedules and sleep disorders influence glycemic control, ca…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
This ClinicalTrials.gov study investigates the clinical and molecular characteristics of primary aldosteronism in Black participants, focusi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Vital Signs Blood Pressure Trial
Stanford University is sponsoring a clinical trial to evaluate blood pressure management in cardiovascular disease and hypertension, which i…
-
FDA approval · 2026-04-23FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application to market a fixed-dose combination tablet of olmesartan medoxomil and hydrochlorothiazide for th…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: HEMODYNAMIC EFFECTS OF LITHOTOMY POSITION IN SURGICAL PATIENTS (PH-LITHO) [NA]
A completed clinical trial evaluating the hemodynamic effects of the lithotomy position in surgical patients, including those with hypertens…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Measurement of High Blood Pressure Using Boppli
This clinical trial update concerns measuring high blood pressure in neonatal hypertension using Boppli. The study is currently not recruiti…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Mobilizing Community Hypertension Access Pilot [NA]
Rush University Medical Center is conducting a clinical trial to mobilize community access to hypertension care and it is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension [Phase 1]
An early Phase 1 study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-850 in participants with hypertensio…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease [Phase 1]
This Phase 1 trial compares valsartan alone versus a combination therapy regimen in hypertensive heart disease to assess relative effectiven…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years [NA]
A clinical trial protocol update outlining a 3-month PILI Pasifika lifestyle program with social determinants of health components to be eva…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program [NA]
Johns Hopkins University's Afro-DPP virtual cardiometabolic health program for African immigrants has completed the trial, with results post…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN [NA]
A clinical trial update indicates the SPYRAL AFFIRM Global Study evaluating renal denervation with the Symplicity Spyral system in subjects …
-
EMA approval · 2026-04-22EMA Authorised: Irbesartan Zentiva (previously Irbesartan Winthrop) (irbesartan) — Zentiva k.s.
The EMA authorised Irbesartan Zentiva for hypertension. It is a generic irbesartan product manufactured by Zentiva k.s.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation [NA]
A clinical trial is evaluating the hemodynamic effects of standardized grape seed extract supplementation in adults with high-normal blood p…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth [NA]
This ClinicalTrials.gov entry updates a pediatric study examining the impact of a produce prescription program and nutrition education on ca…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Navigating Hypertension and Food Insecurity [NA]
A University of Hawaii-sponsored clinical trial addressing hypertension and food insecurity is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
This is an update on a real-world longitudinal study evaluating outcomes of Symplicity Renal Denervation for hypertension, and the trial is …